Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward V Loftus

Showing results (401-410 of 471) with videos related to

Pageof 48
Sort By:
Inflammatory Bowel Diseases|May 2, 2009
Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximabWaqqas Afif, Jonathan A Leighton, Stephen B Hanauer, et al.
The American Journal of Gastroenterology|September 16, 2022
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION TrialSilvio Danese, Marc Ferrante, Brian G Feagan, et al.
Journal of Crohn'S & Colitis|December 23, 2017
De-novo Inflammatory Bowel Disease After Bariatric Surgery: A Large Case SeriesManuel B Braga Neto, Martin Gregory, Guilherme P Ramos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2022
Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction TreatmentEdward V Loftus, Jean-Frederic Colombel, Ken Takeuchi, et al.
Inflammatory Bowel Diseases|June 13, 2020
A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and ChromoendoscopyNayantara Coelho-Prabhu, David H Bruining, William A Faubion, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 21, 2012
Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measuresSunil Samuel, David H Bruining, Edward V Loftus, et al.
Journal of Crohn'S & Colitis|July 24, 2025
Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients with Moderately to Severely Active Crohn's Disease: 2-Year Results from the U-ENDURE Long-Term Extension StudyEdward V Loftus, Geert D'Haens, Edouard Louis, et al.
Gastro Hep Advances|April 20, 2026
Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing CholangitisSiri A Urquhart, Prajith Raj Ramesh, Sunanda V Kane, et al.
The American Journal of Gastroenterology|January 8, 2025
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical TrialBruce E Sands, David T Rubin, Edward V Loftus, et al.
The Lancet. Gastroenterology & Hepatology|September 8, 2023
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance studySéverine Vermeire, Silvio Danese, Wen Zhou, et al.
Pageof 48

Showing results (401-410 of 471) with videos related to

Sort By:
Pageof 48
Inflammatory Bowel Diseases|May 2, 2009
Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximabWaqqas Afif, Jonathan A Leighton, Stephen B Hanauer, et al.
The American Journal of Gastroenterology|September 16, 2022
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION TrialSilvio Danese, Marc Ferrante, Brian G Feagan, et al.
Journal of Crohn'S & Colitis|December 23, 2017
De-novo Inflammatory Bowel Disease After Bariatric Surgery: A Large Case SeriesManuel B Braga Neto, Martin Gregory, Guilherme P Ramos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2022
Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction TreatmentEdward V Loftus, Jean-Frederic Colombel, Ken Takeuchi, et al.
Inflammatory Bowel Diseases|June 13, 2020
A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and ChromoendoscopyNayantara Coelho-Prabhu, David H Bruining, William A Faubion, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 21, 2012
Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measuresSunil Samuel, David H Bruining, Edward V Loftus, et al.
Journal of Crohn'S & Colitis|July 24, 2025
Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients with Moderately to Severely Active Crohn's Disease: 2-Year Results from the U-ENDURE Long-Term Extension StudyEdward V Loftus, Geert D'Haens, Edouard Louis, et al.
Gastro Hep Advances|April 20, 2026
Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing CholangitisSiri A Urquhart, Prajith Raj Ramesh, Sunanda V Kane, et al.
The American Journal of Gastroenterology|January 8, 2025
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical TrialBruce E Sands, David T Rubin, Edward V Loftus, et al.
The Lancet. Gastroenterology & Hepatology|September 8, 2023
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance studySéverine Vermeire, Silvio Danese, Wen Zhou, et al.
Pageof 48